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Abstract: Previous studies report that low levels cognitive function and history of smoking 
are associated with increased mortality risk. Elderly smokers may have increased risk of 
dementia, but risk in former smokers is unclear. We tested the hypotheses that the harmful 
effect of impaired cognitive function as related to mortality is greater in persons smoking at 
baseline than in others. Further, we used serum cotinine levels to assess recall bias of 
smoking  history  by  cognitive  function  level.  Data  were  analyzed  from  a  longitudinal 
mortality follow-up study of 4,916 American men and women aged 60 years and over, 
examined in 1988–1994 with complete data followed an average 8.5 years. Measurements 
at baseline included smoking history, a short index of cognitive function (SICF), serum 
cotinine and socio-demographics. Death during follow-up occurred in 1,919 persons. In 
proportional hazards regression analysis, a significant interaction of current smoking with 
cognitive  function  was  not  found;  but  there  was  a  significant  age-smoking  interaction. 
After adjusting for confounding by age or multiple variables, current smoking associated 
with  over  2-fold  increased  mortality  (hazards  ratio  and  95%  confidence  limits  current 
versus never smoking 2.13, 1.75–2.59) and SICF with 32% reduction in mortality; top 
versus bottom SICF stratum 0.68, 0.53–0.88).  Serum cotinine data revealed substantial 
recall bias of smoking history in persons with cognitive impairment. However analyses 
correcting for this bias did not alter the main conclusions: In a nationwide cohort of older 
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Americans,  analyses  demonstrated  a  lower  risk  of  death  independent  of  confounders 
among those with high SICF scores and never smokers, without a significant interaction of 
the two. 
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1. Introduction 
Both history of smoking and impaired cognitive function are prevalent concomitants of aging in 
industrialized nations [1,2]. Cohort studies of current smoking in elderly persons and dementia or 
Alzheimer’s disease suggest a positive association [3,4]. Validity of smoking history in persons with 
varying degrees of cognitive impairment could be a source of bias in such studies. Cognitive function 
has been found to predict subsequent mortality in elderly adults in a number of previous studies [5]. 
Mechanisms remain obscure. Smoking has been found to be positively related to increased mortality 
from  multiple  causes  [1].  Mechanisms  may  include  inflammation  and  oxidative  stress  leading  to 
atherosclerosis and carcinogenesis. However, information regarding interactions of cognitive function 
and smoking are lacking in studies of mortality.  
We  test  the  hypothesis  that  the  effect  of  cognitive  function  score  on  mortality  is  modified  by 
smoking,  the  effect  being  less  among  never  smokers  compared  to  smokers.  We  further  test  the 
hypothesis that the validity of smoking history is directly associated with cognitive function level. We 
analyzed available data from a national health examination survey linked mortality file conducted with 
scientific sampling and state-of-the-art interviewing, examination and laboratory methods. 
2. Methods 
The Third National Health and Nutrition Examination Survey (NHANES III) was conducted in 
1988–1994  on  a  nationwide  multi-stage  probability  sample  of  39,695  persons  from  the  civilian,  
non-institutionalized population aged 2 months and over of the United States [6]. Persons aged 60 and 
over, African Americans, and Mexican Americans were over-sampled. Details of the plan, sampling, 
operation, response and institutional review board approval have been published as have procedures 
used  to  obtain  informed  consent  and  to  maintain  confidentiality  of  information  obtained  [6].  The 
personal interviews and physical and laboratory examinations of NHANES III subjects provided the 
baseline data for the study. This analysis was based on the public-use version of the NHANES III 
linked-mortality file with mortality data through 2000. Of 33,994 persons with baseline interview data, 
13,944  were  under  age  17  and  26  lacked  data  for  matching  leaving  20,024  eligible  for  mortality 
follow-up. The NHANES III linked mortality file contains information based upon the results from a 
probabilistic match between NHANES III and the NCHS National Death Index records. The NHANES 
III  linked  mortality  file  provides  mortality  follow-up  data  from  the  date  of  NHANES  III  survey 
participation  (1988–1994)  through  31  December  2000.  Of  the  20,022  interviewed  persons  with 
mortality follow-up, 6,588 were aged 60 years and over and eligible to have cognitive function testing 
performed, 6,339 of whom had valid cognitive function data. After excluding persons with missing Int. J. Environ. Res. Public Health 2011, 8                 
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data for any of the variables shown in the tables, 4,916 persons aged 60 and over with complete data 
remained  for  mortality  analyses  (1,919  deaths).  The  length  of  follow-up  of  survivors  
averaged 8.5 years. 
Questions assessing mental cognition were asked only of respondents aged 60 years or older and 
not to proxy respondents [7]. These questionnaires were designed for administration in a bilingual 
(English/Spanish) format so that respondents could be interviewed in their preferred language. The 
neuropsychological  measures  used  in  the  NHANES  III  study,  were  selected  to  assess  cognitive 
functions typically affected in dementia. A short cognitive function index (SICF) was constructed for 
this analysis from these items administered at home interview and/or at a Mobile Examination Center 
to assess orientation, recall and attention (Appendix 1) [7]. Cronbach’s alpha for the index was 0.82  
(n = 4916). Participants were asked, “Have you smoked at least 100 cigarettes in your entire life?” (If 
yes) “Do you smoke cigarettes now?” (If yes) “About how many cigarettes do you smoke per day?” 
Responses were used to classify persons as current, former and never smokers. Serum cotinine levels 
were  measured  by  high-performance  liquid  chromatography  and  atmospheric-pressure  chemical 
ionization tandem mass spectrometry [8-10]. Previous researchers have used the serum cotinine value 
of <14 ng/mL to identify non-smokers. Serum cotinine is directly proportional to absorbed nicotine 
and has a half-life of approximately 20 hours [8]. It is considered a better marker of smoking status 
than self-reported tobacco use. It has been used in a number of reports to document underreporting of 
smoking in various groups [8]. Cotinine data were available for 2,415 of the 4,916 persons for the 
validity sub-analysis. Compared to persons in the analysis (Table 1, Appendix 2), persons aged 60 and 
greater  excluded  were  older  (mean  age  72.65  years)  and  more  likely  to  be  female  (62%),  black 
(10.5%), and not married (47%) but did not differ in Mexican ethnicity or region of residence. 
Estimates of the risk of death from Cox proportional hazards regression models with time-to-event 
as the time scale and other statistics were computed using the survey weights and survey analysis 
procedures in Stata release 11. Survivors were censored at the date of the end of mortality follow-up. 
Proportional hazards assumptions were assessed by  graphical methods.  Logistic regression models 
were utilized to further examine the effect of smoking and SICF on the odds of death. 
3. Results 
3.1. Baseline Analysis 
Table 1 and Appendix 2 show demographic characteristics, SICF score and biomedical variables by 
smoking  status.  Bivariate  analyses  revealed  significant  associations  between  smoking  and  death  
(p < 0.01), SICF score stratum and death (p < 0.01) and between stratum of SICF score and smoking 
status (p = 0.03). In multivariate linear regression analyses, neither baseline SICF scores of current nor 
former smokers differed significantly from those of never smokers at baseline after adjusting for age or 
age category, gender, ethnicity, education and marital status (not shown). Among smokers, number of 
cigarettes smoked daily was not significantly associated with SICF score after adjusting for age or 
multiple confounders. Int. J. Environ. Res. Public Health 2011, 8                 
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Table  1.  Prevalence  (%)  of  selected  characteristics  by  smoking  status  at  baseline  in 
persons aged 60 years and over (N = 4,916). 
   Smoking status 
  All  Never  Former  Current 
N  4,916  2,336  1,827  753 
Dead  32  27  34  39 
Cognitive function index 
<12 
 
19 
 
10 
 
17 
 
23 
12–13  37  35  38  37 
14–16  19  21  19  14 
17  25  23  26  26 
Female  57  73  40  53 
Age 80+   14  20  11  5 
Mexican American  2  2  2  2 
African American  8  6  6  11 
South region  31  31  28  35 
Metropolitan residence  44  43  46  40 
Not married  40  46  31  44 
Education < 12 year  41  41  38  45 
Fair-poor health  28  26  29  32 
≥ 1 chronic illness  56  52  62  52 
Mobility limitation  33  34  30  37 
Low social support  12  10  12  15 
Alcohol in past month  35  25  44  41 
No regular physician  15  14  14  22 
No religious attendance  33  24  38  47 
Systolic BP ≥ 140 mmHg  49  47  50  57 
BMI ≥ 25 kg/m
2  54  51  61  43 
No physical activity  79  79  81  72 
HDL < 40 mg/dL  27  23  31  29 
3.2. Follow-Up Analyses 
In proportional hazards regression models, no significant interaction of SICF and smoking status 
was found (p = 0.119) with hazard of death. Results showed significant interaction of smoking with 
age (p = 0.002). Therefore, further analyses were done within age strata (Table 2). At age 60–69, both 
SICF  score  and  smoking  status  were  significant  predictors  of  death  over  the  follow-up  period. 
However,  the  association  for  smoking  decreased  with  advancing  age  becoming  non-significant  at  
80+ years, unlike that for SICF score. Adjusting in addition for self-reported health status at baseline, 
yielded essentially similar results. Regression analyses were repeated using multiple logistic regression 
(Table 3). These yielded essentially similar results to those shown in Table 2. 
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Table  2.  Adjusted  hazards  ratios*  for  death  for  smoking,  score  on  a  short  index  of 
cognitive function (SICF) in persons aged 60 years and over. 
  HR (95% CL) 
  All  Age 60–69  Age 70–79  Age 80+ 
Smoking status 
Current  2.13  
(1.75–2.59)** 
3.09 
(2.08–4.59)** 
1.70 
(1.29–2.24)** 
1.39 
(0.99–1.97) 
Former  1.45  
(1.25–1.65)** 
1.80 
(1.27–2.54)** 
1.48 
(1.22–1.70)** 
1.16 
(0.95–1.42) 
Never  1.00  1.00  1.00  1.00 
SICF 
17  0.68 
(0.53–0.88)** 
0.65 
(0.39–1.07) 
0.69 
(0.50–0.97)+ 
0.58 
(0.41–0.81)** 
14–16  0.74 
(0.61–0.92)** 
0.54 
(0.35–0.71)** 
0.90 
(0.60–1.34) 
0.77 
(0.65–0.92)** 
12–13  0.73 
(0.63–0.85)** 
0.50 
(0.36–0.71)** 
0.80 
(0.62–1.02) 
0.95 
(0.78–1.16) 
0–11  1.00  1.00  1.00  1.00 
N  4,915  2,102  1,633  1,180 
* adjusted for age, gender, ethnicity, education; ** p < 0.01; + p < 0.05. 
Table  3.  Adjusted  odds  ratios*  for  death  for  smoking  and  score  on  a  short  index  of 
cognitive function (SICF) in persons aged 60 years and over. 
  Age 
Variable  All  60–69  70–79  80+ 
Smoking status 
Current  2.98  
(2.16–4.12)** 
3.89  
(2.51–6.01)** 
1.99  
(1.33–2.97)** 
1.69  
(0.68–4.17) 
Former  1.68  
(1.39–2.05)** 
1.90  
(1.33–2.72)** 
1.55  
(1.20–2.00)** 
2.02  
(1.29–3.18)** 
Never  1.00  1.00  1.00  1.00 
SICF 
17  0.34  
(0.23–0.50)** 
0.33  
(0.18–0.64)** 
0.38  
(0.24–0.59)** 
0.22  
(0.12–0.40)** 
14–16  0.37  
(0.27–0.52)** 
0.28  
(0.18–0.44)** 
0.50  
(0.28–0.88)+ 
0.34  
(0.23–0.49)** 
12–13  0.60  
( 0.47–0.76)** 
0.46  
(0.31–0.69)** 
0.70  
(0.50–1.00)+ 
0.92  
(0.62–1.35) 
0–11  1.00  1.00  1.00  1.00 
N  4,916  2,102  1,633  1,181 
* adjusted for age, gender, ethnicity, education; ** p < 0.01; + p < 0.05. Int. J. Environ. Res. Public Health 2011, 8                 
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3.3. Cognitive Function and Recall Bias 
In past studies of younger populations, self-reported history of never and former smoking with 
serum cotinine ≥ 14 ng/mL were considered false negative histories. In this study, 97.7% (95% CI  
5.8–15.4) of persons who reported current smoking had serum cotinine at that level. Results for those 
reporting former and never smoking are shown in Table 4. There was evidence for a higher rate of 
false negatives in those with low SICF scores than in those with high SICF scores, significantly so for 
those reporting never smoking. 
To assess the effect of misclassification of smoking exposure on associations with mortality, the 
logistic models were repeated using serum cotinine level instead of smoking as the exposure variable 
(reference group: undetectable, medium: detectable but <14 ng/mL, high: ≥14 ng/mL). Adjusted odds 
ratios for the high group were somewhat lower than for the category current smokers in Table 3: all 
2.30 (1.77–3.01, 60–69  2.99 (2.05–4.34), 70–79 2.05 (1.38–3.05), 80+  1.03 (0.56–1.90). Adjusted 
odds ratios for SICF score were little changed and again there was no significant interaction of cotinine 
and SICF score. 
Table 4. Percentage (95% confidence interval) of never and former smokers by self report 
with serum cotinine ≥14 ng/mL score on a short index of cognitive function. 
Stratum of cognitive function 
and smoking status by self report 
Lowest (score < 12)  Highest (score > 16) 
Never  Former  Never  Former 
10.8 (7.3–15.6)  16.4 (10.9–23.7)  2.3 (1.1–4.6)  9.6 (6.0–15.2) 
4. Discussion  
This  analysis  of  data  from  the  NHANES  III  linked-mortality  file,  a  nation-wide  representative 
sample, is the first study to test for interaction of cognitive function and smoking as predictors of 
survival in older Americans and the first to assess the effect of recall bias with low cognitive function 
on such analyses.  Both smoking and poor cognitive function were found to independently predict 
diminished survival chances over follow-up, consistent with previous studies [5,11,12]. However, no 
interaction of the two was detected. A bivariate association between smoking and cognitive function 
was no longer significant after controlling for age or multiple confounders. Recall bias was substantial 
but correcting for this bias did not alter the main conclusions of the follow-up analysis. These findings 
support efforts to effect smoking cessation and to develop effective prevention of cognitive decline 
among the elderly. 
The  NHANES  III  provides  population-based  data  on  the  independent  association  of  smoking, 
cognitive function with survival in a nation-wide representative sample of Americans. Over-sampling 
of  persons  aged  60  and  over  permitted  reliable  estimates  for  this  group  [6].  However,  several 
unavoidable limitations of the present study include possible bias arising from survey non-response 
and exclusion due to missing values for some variables, and from possible changes in smoking and 
cognitive function and/or other variables over the follow-up period. In Cox regression analysis, plots 
of  -log-log  survival  curves  suggested  possible  violations  of  proportional  hazards  assumptions. Int. J. Environ. Res. Public Health 2011, 8                 
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However,  logistic  regression  analyses  produced  essentially  the  same  results.  A  model  including 
presence of major comorbidities at baseline produced essentially the same results as reported above 
(Table  2).  However,  the  possibility  of  residual  confounding  by  unmeasured  variables  cannot  be 
excluded. Further longitudinal studies with repeated measures of smoking status, duration and amount, 
and multiple dimensions of cognition and Alzheimer’s disease biomarkers would be helpful. 
5. Conclusions 
In a nationwide cohort of older Americans, analyses demonstrated a lower risk of death independent 
of confounders among those with high SICF scores and never smokers without a significant interaction 
of the two. 
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Appendix 
Appendix 1. NHANES III short index of cognitive function items (NHANES III variable 
name and question). 
Orientation 
1.  HAA4D  What is today’s date? 
2.  HAA5D  What is the day of the week? 
3.  HAA6AD  What is your complete address: street? 
4.  HAA6BD  What is your complete address: city? 
5.  HAA6CD  What is your complete address: state? 
6.  HAA6DD  What is your complete address: zip code? 
Immediate recall (3 objects: apple, table, penny after 0 minutes and 5 minutes) 
7.  HAP17A1D  Apple immediate recall 
8.  HAP17A2D  Table immediate recall 
9.  HAP17A3D  Penny immediate recall 
Simple math (serial subtraction of $3 from $20) 
10.  HAP18AD  First subtraction ($17) 
11.  HAP18BD  Second subtraction ($14) 
12.  HAP18CD  Third subtraction ($11) 
13.  HAP18DD  Fourth subtraction ($7) 
14.  HAP18ED  Fifth subtraction ($4) 
Delayed recall (of three objects above) 
15.  HAP19AD  Apple 
16.  HAP19BD  Table 
17.  HAP19CD  Penny Int. J. Environ. Res. Public Health 2011, 8                 
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Appendix 1. Cont. 
SAS Program Code for Computing SICF Score * 
ARRAY Q [17] HAA4 HAA5 HAA6A HAA6B HAA6C HAA6D HAP17A1 HAP17A2 HAP17A3 HAP18AR  
        HAP18BR HAP18CR HAP18DR HAP18ER HAP19A HAP19B HAP19C; 
ARRAY  R  [17]  HAA4D  HAA5D  HAA6AD  HAA6BD  HAA6CD  HAA6DD  HAP17A1D  HAP17A2D 
HAP17A3D   
        HAP18AD HAP18BD HAP18CD HAP18DD HAP18ED HAP19AD HAP19BD HAP19CD; 
                                      Do I=1 TO DIM(Q); 
                                      Do I=1 to DIM(R); 
                                                IF Q[I]=1 THEN R[I]=R[I] + 1; 
                                                Else IF Q[I]=2 THEN R[I]=R[I] + 0; 
                                                Else IF Q[I] NE 1 and Q[I] NE 2 THEN R[I]=.; 
                                                         END; 
                                                         End; 
                                                                Drop I; 
SICF_SCORE=SUM(OF  HAA4D  HAA5D  HAA6AD  HAA6BD  HAA6CD  HAA6DD  HAP17A1D 
HAP17A2D  HAP17A3D  HAP18AD  HAP18BD  HAP18CD  HAP18DD  HAP18ED  HAP19AD  HAP19BD 
HAP19CD); 
* One point given for each correct answer to items 1–17 (Score ranges from 0 to 17). 
Cronbach’s alpha = 0.82 (n = 4,916) 
Appendix 2. Mean (se) of selected continuous characteristics by smoking status at baseline 
in persons aged 60 years and over (N = 4,916). 
Smoking status 
  All  Never  Former  Current 
N  4,916  2,336  1,827  753 
Cognitive function index 
 Score 
 
13.66 
(0.34) 
 
13.55 
(0.34) 
 
13.85 
(0.35) 
 
13.49 
(0.39) 
 
Age (years)   69.90 
(0.22) 
71.03 
(0.38) 
69.64 
(0.19) 
67.19 
(0.25) 
 
Systolic BP ≥ 140mmHg  138.32 
(0.44) 
139.65 
(0.71) 
137.88 
(0.61) 
135.55 
(1.19) 
 
BMI kg/m
2  26.99 
(0.12) 
27.10 
(0.19) 
27.45 
(0.13) 
25.43 
(0.27) 
 
HDL mg/dL 
 
 
Total cholesterol mg/dL 
 
51.31 
(0.42) 
 
223.76 
(1.08) 
52.70 
(0.45) 
 
226.78 
(1.47) 
50.00 
(0.71) 
 
221.74 
(1.50) 
50.72 
(0.87) 
 
220.13 
(1.72) 
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